Lucentis effective for proliferative diabetic retinopathy

The National Eye Institute is very pleased today to announce new clinical trial results that will benefit people at risk of vision loss from diabetic retinopathy. The trial demonstrates that injections of the drug Lucentis are effective in treating proliferative diabetic retinopathy, or PDR. I think this study will have a major impact on the…

Scott D. Halpern, M.D., Ph.D., M.Bioethics

>>Scott Halpern: So I’m going to talk about some work that was funded through the Science and Behavior Change Program. And specifically through the National Cancer of Institute’s funding through that program, but also by a grant from the National Institute on Aging. To my colleagues, Kevin Volpp and David Asch, which established a research…